您的位置: 首页 > 农业专利 > 详情页

TRAITEMENT DE PATIENTS GRAVEMENT ATTEINTS PAR DE L'IBUPROFENE PAR VOIE INTRAVEINEUSE
专利权人:
CUMBERLAND PHARMACEUTICALS INC.
发明人:
PAVLIV, LEO,ROCK, AMY DIX
申请号:
CA2785360
公开号:
CA2785360C
申请日:
2010.12.22
申请国别(地区):
CA
年份:
2017
代理人:
摘要:
Methods of treating at least one condition chosen from pain, inflammation, andfever in a critically ill patient inneed thereof, comprising administering to the critically ill patient anintravenous pharmaceutical composition comprisingibuprofen using a first dosage regimen, wherein the first dosage regimenproduces a first pharmacokinetic profile in critically ill patientsthat is about equivalent to a second pharmacokinetic profile produced byadministration of the intravenous pharmaceuticalcomposition using a second dosage regimen of ibuprofen to non- critically illpatients, wherein the at least one condition of the criticallyill patient is thereby treated.
来源网站:
中国工程科技知识中心
来源网址:
http://www.ckcest.cn/home/

意 见 箱

匿名:登录

个人用户登录

找回密码

第三方账号登录

忘记密码

个人用户注册

必须为有效邮箱
6~16位数字与字母组合
6~16位数字与字母组合
请输入正确的手机号码

信息补充